|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research and development costs | |||||
| Selling, general and administrative expenses | |||||
| Impairment of CUI tradename | |||||
| Restructuring (credits) charges | |||||
| Gain on sale of properties | |||||
| Earnout liability adjustments | |||||
| Income from operations | |||||
| Gain on sale of Czech Republic business | |||||
| Other income/expense, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Impairment of equity method investment and related party notes | |||||
| Other income (expense), net | |||||
| Earnings before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net earnings available to common shareholders | |||||
| Less: Net earnings attributable to noncontrolling interest | |||||
| Redemption value adjustment attributable to noncontrolling interest | |||||
| Net earnings attributable to Bel Fuse shareholders | |||||
| Common Class A | |||||
| Common Class B | |||||
| Total net earnings attributable to Bel Fuse shareholders | |||||
| Net earnings per common share: | |||||
| Net earnings per common share, basic (in dollars per share) | |||||
| Common Class A | |||||
| Common Class B | |||||
| Net earnings per common share, diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Weighted-average number of shares outstanding - basic (in shares) | |||||
| Common Class A | |||||
| Common Class B | |||||
| Weighted-average number of shares outstanding - diluted (in shares) | |||||
Loading...